ENGASE
Cytosolic endo-beta-N-acetylglucosaminidase
Also known as: ENASE_HUMAN, FLJ21865
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NFI3
- Gene
- ENGASE
- Ensembl
- ENSG00000167280
- Chromosome
- 17
- Canonical length
- 743 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Centrosome,Cytosol
OverviewNCBI Gene
This gene encodes a cytosolic enzyme which catalyzes the hydrolysis of peptides and proteins with mannose modifications to produce free oligosaccharides. [provided by RefSeq, Feb 2012]
Canonical amino-acid sequenceUniProt
743 residues, UniProt reviewed canonical sequence.
>Q8NFI3|ENGASE
1 MEAAAVTVTR SATRRRRRQL QGLAAPEAGT QEEQEDQEPR PRRRRPGRSI KDEEEETVFR
61 EVVSFSPDPL PVRYYDKDTT KPISFYLSSL EELLAWKPRL EDGFNVALEP LACRQPPLSS
121 QRPRTLLCHD MMGGYLDDRF IQGSVVQTPY AFYHWQCIDV FVYFSHHTVT IPPVGWTNTA
181 HRHGVCVLGT FITEWNEGGR LCEAFLAGDE RSYQAVADRL VQITQFFRFD GWLINIENSL
241 SLAAVGNMPP FLRYLTTQLH RQVPGGLVLW YDSVVQSGQL KWQDELNQHN RVFFDSCDGF
301 FTNYNWREEH LERMLGQAGE RRADVYVGVD VFARGNVVGG RFDTDKSLEL IRKHGFSVAL
361 FAPGWVYECL EKKDFFQNQD KFWGRLERYL PTHSICSLPF VTSFCLGMGA RRVCYGQEEA
421 VGPWYHLSAQ EIQPLFGEHR LGGDGRGWVR THCCLEDAWH GGSSLLVRGV IPPEVGNVAV
481 RLFSLQAPVP PKIYLSMVYK LEGPTDVTVA LELTTGDAGS CHIGGISVLN AETSSRHSLR
541 PLRVPPTKLA RWVGRCGRQL SGGWVQHCYE VSLRGCLLLD LLVCFSRPPG SREEESFTCR
601 LGEIQVVDAA SLLAPLPQVQ AVTISHIRWQ PSASEREGPP ALLQLSCTLH WSFLLSQVRC
661 FRIHCWGGMS DDSPGRELPR PEMPMFLGLA FATQYRIVDL LVEAAGPGQD RRMEFLVEPV
721 PKEGFRVPQA EWGRAVLLYS APALocalizationUniProt · AlphaFold · HPA
Whether an antibody against ENGASE can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 22 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 22 nTPM
- spleen: 21 nTPM
- ovary: 17 nTPM
- colon: 17 nTPM
- small intestine: 16 nTPM
- urinary bladder: 15 nTPM
Single-cell type
- myonuclei: 68 nCPM
- microglia: 31 nCPM
- colonocytes: 28 nCPM
- enteric stem cells: 28 nCPM
- macrophages: 26 nCPM
- adrenal cortex cells: 25 nCPM
Immune cell
- T-reg: 0.7 nTPM
- naive CD4 T-cell: 0.5 nTPM
- myeloid DC: 0.4 nTPM
- NK-cell: 0.4 nTPM
- classical monocyte: 0.3 nTPM
- MAIT T-cell: 0.2 nTPM
Brain region
- white matter: 21 nTPM
- cerebral cortex: 21 nTPM
- thalamus: 19 nTPM
- midbrain: 18 nTPM
- choroid plexus: 17 nTPM
- pons: 17 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.34
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.02
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- BRCT domain
- Cytosolic endo-beta-N-acetylglucosaminidase, TIM barrel domain
- Cytosolic endo-beta-N-acetylglucosaminidase
- Cytosolic endo-beta-N-acetylglucosaminidase, C-terminal domain
- Glycosyl hydrolase family 85
- ENGASE1-like, C-terminal immunoglobulin-like domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ENGASE as an antibody target. Whether an autoantibody or antibody against ENGASE could matter depends on whether native ENGASE is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ENGASE is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ENGASE as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...